Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00410371 · ClinicalTrials.gov registry record · Phase 1
Study to Compare Two Formulations of Lamotrigine in Healthy Subjects
A Phase 1 study of Mental Disorders, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT00410371: Completed Phase 1 study of Mental Disorders, sponsored by GlaxoSmithKline.
NCT00410371 is a Phase 1 study of Mental Disorders that has completed, run by GlaxoSmithKline. The registered enrollment target is 96 participants, below the 681-participant average among 25 other Mental Disorders trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00410371, a Phase 1 study of Mental Disorders, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
This study intends to compare the pharmacokinetic characteristics, safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
Conditions Studied
Interventions
- DRUG Lamotrigine
- DRUG GI267119
Study Locations (1)
Nebraska
- GSK Investigational Site - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2006-12-28 |
| Est. Completion | 2007-01-25 |
| Phase | Phase 1 |
What the finished NCT00410371 record still lists
NCT00410371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 681-participant average among 25 other Mental Disorders trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Mental Disorders appearing as the primary indexed condition, and to 2 interventions - of which Lamotrigine is the first listed.
NCT00410371 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT00410371 about?
NCT00410371 is a clinical study titled "Study to Compare Two Formulations of Lamotrigine in Healthy Subjects". This study intends to compare the pharmacokinetic characteristics, safety and tolerability of two formulations of lamotrigine in healthy male and female volunteers
What is the current status of trial NCT00410371?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2006-12-28. Estimated completion is 2007-01-25.
What conditions does trial NCT00410371 study?
This clinical trial studies the following conditions: Mental Disorders.
What interventions are being tested in trial NCT00410371?
The interventions under investigation include: Lamotrigine (DRUG), GI267119 (DRUG).
Who is sponsoring clinical trial NCT00410371?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00410371 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00410371's enrollment target sits among peer trials
96 18th of 25 higher than 8 of 25 other Mental Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Relative Bioavailability of LY03010 Compared to Listed Drug
COMPLETED · Phase 1
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Stimulation-Induced Changes in Fronto-Limbic Network
RECRUITING · NA
-
Studying the Health of Asians to Advance Knowledge, Treatments, and Interventions for Depression
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI